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Genes embedded in H3 lysine 9 methylation (H3K9me)–dependent 2 
heterochromatin are transcriptionally silenced1-3. In fission yeast, 3 
Schizosaccharomyces pombe, H3K9me-mediated heterochromatin can be 4 
transmitted through cell division provided the counteracting demethylase Epe1 5 
is absent4,5. Under certain conditions wild-type cells might utilize 6 
heterochromatin heritability to form epimutations, phenotypes mediated by 7 
unstable silencing rather than DNA changes6,7. Here we show that resistant 8 
heterochromatin-dependent epimutants arise in threshold levels of caffeine. 9 
Unstable resistant isolates exhibit distinct heterochromatin islands, which 10 
reduce expression of underlying genes, some of which confer resistance when 11 
mutated. Targeting synthetic heterochromatin to implicated loci confirms that 12 
resistance results from heterochromatin-mediated silencing. Our analyses 13 
reveal that epigenetic processes promote phenotypic plasticity, allowing wild-14 
type cells to adapt to non-favorable environments without altering their 15 
genotype. In some isolates, subsequent or co-occurring gene amplification 16 
events augment resistance. Caffeine impacts two anti-silencing factors: Epe1 17 
levels are downregulated, reducing its chromatin association; and Mst2 histone 18 
acetyltransferase expression switches to a shortened isoform. Thus, 19 
heterochromatin-dependent epimutant formation provides a bet-hedging 20 
strategy that allows cells to remain genetically wild-type but adapt transiently 21 
to external insults. Unstable caffeine-resistant isolates show cross-resistance 22 
to antifungal agents, suggesting that related heterochromatin-dependent 23 
processes may contribute to antifungal resistance in plant and human 24 
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 3 
Main Text: 32 
H3K9me-heterochromatin can be copied by a read-write mechanism4,5,8 and has 33 
been observed to arise stochastically at various loci, albeit only in the absence of key 34 
anti-silencing factors9-13 or specific growth conditions14. We reasoned that if 35 
heterochromatin can redistribute in wild-type S. pombe cells, epimutations could be 36 
generated, allowing adaption to external insults. Unlike genetic mutants we predicted 37 
that such epimutants would be unstable, resulting in gradual loss of resistance 38 
following growth without the insult. We chose to use caffeine because deletion of 39 
genes with a variety of cellular roles confers caffeine resistance15, thereby increasing 40 
the chance of obtaining epimutations. We also reasoned that unstable epimutants 41 
would occur more frequently at moderate caffeine concentrations that prevent most 42 
cells from growing (16 mM) rather than the higher stringency (20 mM) used in screens 43 
for genetic caffeine-resistant mutants15.  44 
As secondary events might occur upon prolonged growth on caffeine, we froze an 45 
aliquot of each isolate upon resistant colony formation and also froze consecutive 46 
aliquots of each isolate after continued growth on caffeine (Fig. 1a). This ‘time series’ 47 
permitted detection and separation of potential initiating and subsequent events. 48 
Colonies that grew after plating wild-type fission yeast (972 h-) cells in 16 mM caffeine 49 
(+CAF) were picked. Following freezing, isolates were then successively propagated 50 
without caffeine (-CAF). Re-challenging isolates with caffeine revealed that 23% lost 51 
caffeine resistance after 14 days of non-selective growth (‘unstable resistant’, UR) 52 
whereas 13% remained caffeine resistant (‘stable resistant’, SR). 64% of isolates did 53 
not display a clear phenotype (‘unclear’) (Fig. 1b and Extended Data Fig. 1a-c). 54 
Deletion of clr4+ (the sole S. pombe H3K9 methyltransferase16,17), but not a control 55 
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locus, from resistant isolates resulted in loss of caffeine resistance in unstable, but 56 
not stable isolates (Fig. 1c and Extended Data Fig. 1d). Thus, caffeine resistance in 57 
unstable isolates requires heterochromatin.  58 
Whole genome sequencing (WGS) of stable isolate SR-1 uncovered a mutation in 59 
pap1+ responsible for the caffeine-resistant phenotype (Extended Data Fig. 1e)18. 60 
ChIP-seq for H3K9me2 on SR-1 revealed no changes in heterochromatin distribution. 61 
WGS of unstable isolates revealed no genetic changes in any sequence involved in 62 
either caffeine resistance or H3K9me2-mediated silencing, and 8 of 30 analyzed 63 
unstable isolates had no detectable genetic change compared to wild-type (Extended 64 
Data Fig. 2a-e and Supplementary Table 1).  65 
H3K9me2 ChIP-seq on unstable isolates revealed altered heterochromatin 66 
distributions. UR-1 exhibited a new H3K9me2 island over the hba1 locus, whereas 67 
UR-2-to-UR-6 exhibited H3K9me2 islands over the ncRNA.394, ppr4, grt1, fio1 and 68 
mbx2 loci, respectively (Fig. 2 and Supplementary Table 1). Deletion of hba1+ confers 69 
caffeine resistance19, suggesting that caffeine-induced heterochromatin islands may 70 
drive resistance by silencing underlying genes. Accordingly, RT-qPCR analysis 71 
revealed reduced expression of genes underlying the observed hba1 72 
heterochromatin island (Extended Data Fig. 2f). 73 
The ncRNA.394, ppr4, grt1, fio1 and mbx2 loci have not previously been implicated 74 
in caffeine resistance. Interestingly, 24/30 unstable isolates exhibited a 75 
heterochromatin island over the ncRNA.394 locus (Extended Data Fig. 3a, b and 76 
Supplementary Table 1), and reduced underlying transcript levels (Extended Data Fig. 77 
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2f and 3c), suggesting that transcriptional silencing within these loci mediates 78 
caffeine resistance. 79 
ncRNA.394 was previously identified as a heterochromatin island that gains 80 
H3K9me2 in the absence of counteracting Epe1 demethylase9,20. We detected no 81 
H3K9me2 over ncRNA.394 in untreated wild-type cells (Fig. 2b and Extended Data 82 
Fig. 3a, b). Deletion of ncRNA.394 did not result in caffeine resistance (Extended Data 83 
Fig. 3d). Prolonged growth without caffeine of cells exhibiting the ncRNA.394 84 
heterochromatin island resulted in H3K9me2 loss over this region, whereas growth 85 
with caffeine extended the H3K9me2 domain over the SPBC17G9.13c+ and 86 
SPBC17G9.12c+ genes (Extended Data Fig. 3e). Deletion of SPBC17G9.12c+ or 87 
eno101+ did not result in caffeine resistance (Extended Data Fig. 3d). SPBC17G9.13c+ 88 
is essential for viability, precluding testing its deletion for resistance.  89 
To test if heterochromatin formation at these specific loci alone results in caffeine 90 
resistance, tetO binding sites were inserted at hba1, ncRNA.394 and mbx2 loci to 91 
force synthetic heterochromatin assembly upon recruitment of TetR-Clr4* fusion 92 
protein4,5. Combining tetO with TetR-Clr4* without anhydrotetracycline (-AHT) 93 
resulted in novel H3K9me2 domains and growth on caffeine (Fig. 3 and Extended 94 
Data Fig. 4a-d). Thus, heterochromatin-mediated silencing at hba1, ncRNA.394 or 95 
mbx2 loci results in caffeine resistance.  96 
Remarkably, strains with forced synthetic heterochromatin at either hba1 or 97 
ncRNA.394 loci displayed resistance to the widely-used antifungals clotrimazole, 98 
tebuconazole and fluconazole (Fig. 3 and Extended Data Fig. 4e). Unstable caffeine-99 
resistant isolates with heterochromatin islands at hba1 (UR-1) or ncRNA.394 (UR-2) 100 
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loci also displayed resistance to antifungals and produced small interfering RNAs 101 
(siRNAs) homologous to surrounding genes (Extended Data Fig. 5a-c). Consistent 102 
with RNAi pathway involvement, caffeine resistance was abolished upon removal of 103 
RNAi components (dcr1D, ago1D; Extended Data Fig. 5d). 104 
TetR-Clr4* tethering close to SPBC17G9.13c+, upstream of ncRNA.394, resulted in 105 
caffeine resistance (Fig. 3c), suggesting that reduced SPBC17G9.13c+ expression 106 
may mediate resistance. We therefore reduced expression of SPBC17G9.13c+ 107 
(named cup1+, caffeine unstable phenotype 1) by increasing degradation of its mRNA 108 
(LocusPX:cup1-3xDSR) or attenuating its transcription (cup1-TT; see Methods). Both 109 
approaches resulted in reduced cup1+ transcript levels and caffeine resistance 110 
(Extended Data Fig. 6a, b). Cup1 contains a LYR domain often found in mitochondrial 111 
proteins21 and Cup1-GFP exhibited mitochondrial localisation (Extended Data Fig. 112 
6c). LYR-domain mutation led to caffeine resistance (Extended Data Fig. 6d). Thus, 113 
reduced expression or mutation of mitochondrial protein Cup1 (SPBC17G9.13c) 114 
renders cells caffeine resistant. We conclude that cup1+ silencing by heterochromatin 115 
island formation mediates caffeine resistance. 116 
In addition to the ncRNA.394/cup1 heterochromatin island, analysis of ChIP-seq 117 
input DNA indicated that many independent unstable caffeine-resistant isolates also 118 
contained increased copy number of a chromosome III region (Extended Data Fig. 119 
7a). The minimal region of overlap in 11/12 isolates contained cds1+, whose 120 
overexpression confers caffeine resistance22. To determine if cds1+ amplification 121 
occurred before or after ncRNA.394/cup1 heterochromatin island formation, we 122 
analyzed UR-2 samples frozen at earlier and later time points. The ncRNA.394/cup1 123 
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H3K9me2 island was detected in the initial caffeine-resistant isolate (4day/+CAF), 124 
whereas cds1 locus amplification arose later (7day/+CAF) (Extended Data Fig. 7b). 125 
Thus, development of resistance appears to be a multistep process where 126 
combinatorial events facilitate adaption to the insult. 127 
In agreement with this hypothesis, deletion of clr4+ from the initial UR-2 isolate 128 
(4day/+CAF) resulted in caffeine resistance loss in all transformants (6/6). However, 129 
only half of the transformants (3/6; transformants 1, 4 and 5) lost caffeine resistance 130 
upon clr4+ deletion from the later UR-2 isolate with cds1 locus amplification 131 
(7day/+CAF). Transformants that retained resistance after clr4+ removal (3/6; 132 
transformants 2, 3 and 6) exhibited higher cds1+ copy numbers compared to clr4D  133 
transformants that lost resistance or to wild-type cells (Extended Data Fig. 7c). We 134 
conclude that once cds1 locus amplification occurs heterochromatin is no longer 135 
required for caffeine resistance. In UR-2 the new ncRNA.394/cup1 heterochromatin 136 
island arose before cds1+ amplification, but it is likely that these events are stochastic 137 
and occur in no fixed order. Interestingly, both adaptations – island formation and 138 
locus amplification – are unstable and lost following growth without caffeine 139 
(Extended Data Fig. 7d). 140 
Instability of the amplified region suggested it resulted from excision and 141 
extrachromosomal circular DNA (eccDNA) formation which can be rapidly 142 
accumulated and lost23-26. CNV plots revealed repetitive elements at junctions of 143 
putative eccDNA (5S rRNA.24/26 for UR-2 (7day/+CAF) and LTR3/27 for UR-4). PCR 144 
specific for putative circle junctions and Southern analysis confirmed the presence of 145 
chromosome-III-derived eccDNA (Extended Data Fig. 8). Therefore, repeat-mediated 146 
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eccDNA generation provides an alternative, or supplementary, mechanism for the 147 
evolution of caffeine, and perhaps other, resistances in fission yeast. Accumulation 148 
of additional changes may allow further adaption to insults through other pathways 149 
or by bolstering silencing at particular loci27. 150 
To investigate the dynamics of heterochromatin island formation in response to 151 
caffeine we exposed wild-type cells to low (7 mM) or medium (14 mM) doses of 152 
caffeine. Cells in low or medium caffeine doubled ~8 or ~3 times, respectively, in 18 153 
hours (Extended Data Fig. 9a). Several H3K9me2 heterochromatin islands were 154 
detected following exposure to low caffeine (Fig. 4a top and Extended Data Fig. 9b, 155 
c). These low-caffeine-induced islands represent a subgroup of those that 156 
accumulate H3K9me2 in the absence of Epe19,10,12, including ncRNA.394/cup1, but 157 
did not overlap with H3K9me2-heterochromatin domains that accumulate without 158 
nuclear exosome function13 or at 18oC14. Remarkably, ectopic heterochromatin was 159 
restricted to ncRNA.394/cup1 following medium caffeine treatment and H3K9me2 160 
levels at this locus were ~4-fold greater after medium compared to low caffeine 161 
exposure (Fig. 4a and Extended Data Fig. 9d). These data indicate that exposure to 162 
near-lethal doses of caffeine (14 mM) allows wild-type cells to develop resistance 163 
rapidly by forming heterochromatin over a locus (ncRNA.394/cup1) that confers 164 
resistance when silenced. 165 
To determine if other insults also induce heterochromatin islands, we exposed wild-166 
type cells to oxidative stress (1 mM hydrogen peroxide). Heterochromatin islands 167 
were detected at similar locations to those observed in low caffeine, albeit H3K9me2 168 
levels were lower (Extended Data Fig. 9b, c and e).  169 
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The heterochromatin profile of wild-type cells treated with low caffeine resembles that 170 
of untreated epe1D cells (Extended Data Fig. 9c). We hypothesized that caffeine might 171 
negatively regulate Epe1, thereby allowing adaptive ectopic heterochromatin islands 172 
to form in wild-type cells. TetR-Clr4*-mediated synthetic heterochromatin can be 173 
transmitted through cell division upon release of TetR-Clr4* from tetO sites only in 174 
cells lacking Epe14,5. To further test if caffeine imparts an epe1D-like phenotype, we 175 
treated wild-type cells with low caffeine and released TetR-Clr4* from 4xtetO sites 176 
inserted at ura4+ (Fig. 4b). Caffeine treatment, like epe1D, allowed heterochromatin 177 
retention at the tethering site for longer compared to untreated cells. epe1+ RNA 178 
levels were not significantly altered by caffeine, suggesting post-transcriptional 179 
regulation (Extended Data Fig. 9f). 3xFLAG-Epe1 levels decreased by 33% and Epe1 180 
association with various heterochromatic locations was reduced following exposure 181 
to caffeine (Fig. 4c, d). These data suggest that down-regulation of Epe1 putative 182 
H3K9 demethylase levels plays a critical role in the response to external insults by 183 
allowing formation of adaptive ectopic H3K9me-heterochromatin islands that, in turn, 184 
reduce expression of underlying genes to confer resistance. Consistent with this 185 
scenario, epe1D cells form more, and clr4D cells fewer, caffeine resistant colonies 186 
than wild-type cells (Extended Data Fig. 9g).  187 
Although caffeine down-regulates Epe1 protein levels, higher levels of H3K9me2 188 
accumulate at heterochromatin islands following caffeine exposure than in untreated 189 
epe1Δ cells (Extended Data Fig. 9c). Therefore, reduced Epe1 levels alone cannot 190 
account for the high levels of H3K9me2 observed at islands upon caffeine treatment. 191 
Mst2 histone acetyltransferase acts synergistically with Epe1 to prevent 192 
heterochromatin island formation10. Interestingly, caffeine exposure results in 193 
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production of a shorter Mst2 protein by wild-type cells (52 kDa versus 62 kDa; 194 
Extended Data Fig. 10a). RNA-seq suggests this shorter isoform arises through use 195 
of an alternative transcriptional start site in caffeine, such as that detected in other 196 
stresses28 (Extended Data Fig. 10b). We suggest that this caffeine-induced shortened 197 
Mst2 isoform, lacking the MYST-Zinc finger domain29, may be inactive and unable to 198 
prevent heterochromatin island formation. Thus, caffeine, by both lowering Epe1 199 
levels and likely disabling Mst2, allows greater accumulation of H3K9me2 at islands 200 
than in epe1Δ cells. These findings reveal an adaptive epigenetic response to external 201 
insults that stimulates phenotypic plasticity, and suggest that stress-response 202 
pathways may regulate heterochromatin modulation activities, thereby ensuring cell 203 
survival in fluctuating environmental conditions (Fig. 4e).  204 
DNA methylation-dependent epimutations frequently arise in plants and are 205 
propagated by maintenance methyltransferases30,31. RNAi-mediated epimutations 206 
occur in the fungus Mucor circinelloides32, but their DNA methylation or 207 
heterochromatin dependence is unknown. As fission yeast lacks DNA methylation33,34 208 
this epigenetic mark cannot be responsible for the epimutations described here. 209 
Instead our analyses indicate that these adaptive epimutations are transmitted in 210 
wild-type cells by the Clr4/H3K9me read-write mechanism4,5,8. 211 
Why have epimutants not been detected previously in mutant screens? Stringent 212 
phenotypic screens mean strong mutants are investigated further and eccentric 213 
mutants discarded. Here we selected for weak mutants by applying sublethal doses 214 
of drug at the threshold of growth prevention. Selection was time-limited to maximize 215 
identification of isolates exhibiting unstable phenotypes prior to development of 216 
genetic alterations. 217 
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Fungal infections are on the rise, especially in immunocompromised humans. Few 218 
effective antifungal agents exist and resistance is rendering them increasingly 219 
ineffective35. Widespread use of related azole compounds to control fungus-mediated 220 
crop deterioration may leave residual antifungals in the soil, possibly allowing 221 
unwitting selection of resistant epimutants in fungi, ultimately driving increasing cases 222 
of azole-resistant Aspergillosis and Cryptococcosis in the clinic. Monitoring 223 
resistance in clinical isolates involves mutation identification by genome sequencing, 224 
but resistance due to epimutations – similar to those described here – would be 225 
missed, leading to inaccurate diagnoses. Re-engineering existing so-called 226 
‘epigenetic drugs’ – compounds that inhibit histone-modifying enzymes – or 227 
development of novel agents, may identify molecules that specifically block fungal, 228 
not host, heterochromatin formation, hence reducing the emergence of antifungal 229 
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Figure 1. Identification of heterochromatin-dependent epimutants resistant to 334 
caffeine 335 
a, Screening strategy. S. pombe wild-type (wt) cells were plated on caffeine-336 
containing (+CAF) media. Caffeine-resistant isolates were picked and grown on +CAF 337 
for 4 days. Isolates were then grown on +CAF for a total of 7 or 20 days or on non-338 
selective (-CAF) media for 2 and 14 days. 339 
b, Unstable (UR) and stable (SR) caffeine-resistant isolates were identified. After non-340 
selective growth for 2 and 14 days, caffeine-resistant isolates were serially diluted 341 
and spotted on -CAF and +CAF plates to assess resistance to caffeine. 342 
c, Caffeine resistance in UR isolates depends on the Clr4 H3K9 methyltransferase. 343 
clr4+ (clr4Δ) or an unlinked intergenic region (controlΔ) were deleted in unstable (UR-344 
1) and stable (SR-1) caffeine-resistant isolates.  345 






Figure 2. Ectopic islands of heterochromatin are detected in unstable (UR) 352 
caffeine-resistant isolates 353 
a-b, Genome-wide (a) and locus-specific (b) H3K9me2 ChIP-seq enrichment in wild-354 
type (wt) cells and UR isolates. Data are represented as relative fold enrichment over 355 
input. Sequencing was performed once, and results were confirmed by qChIP. Red 356 
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Figure 3. Forced synthetic heterochromatin targeting to the identified loci is 365 
sufficient to drive caffeine resistance in wild-type cells 366 
a, TetR-Clr4* mediates H3K9me deposition at 4xtetO binding sites. Addition of 367 
anhydrotetracycline (+AHT) releases TetR-Clr4* from 4xtetO sites, resulting in 368 
removal of H3K9me. 369 
b-d, Wild-type (wt) cells harbouring 4xtetO binding sites at the hba1 or ncRNA.394 370 
loci (or ura4 as control) and expressing TetR-Clr4* were assessed for caffeine (+CAF) 371 
or clotrimazole (+CLZ) resistance in the absence or presence of AHT. qChIP of 372 
H3K9me2 levels on hba1 (b), SPBC17G9.13c (c) and ura4 (d) loci. Data are mean ± 373 
s.d. from three biological replicates. Dumbbells indicate primer pairs used. Red 374 






















Figure 4. Dynamic heterochromatin redistribution following short exposure to 396 
caffeine in wild-type cells 397 
a, H3K9me2 ChIP-seq enrichment at ncRNA.394/cup1 and mcp7 loci (or at 398 
pericentromeric dgI/dhI repeats of chromosome I as control) in wild-type (wt) cells 399 
following 18 hr exposure to low (7 mM, top) or medium (14 mM, bottom) 400 
concentrations of caffeine. Data are represented as relative fold enrichment over 401 
input. Red arrows indicate essential genes.  402 
b, Effect of caffeine treatment on retention of synthetic heterochromatin upon release 403 
of tethered Clr4 methyltransferase. qChIP of H3K9me2 levels on 4xtetO-ura4+ before 404 
and after TetR-Clr4* release in wt cells untreated or treated with low caffeine. epe1Δ 405 
cells were used as positive control. Dumbbells indicate primer pairs used. H3K9me2 406 
levels were normalized to spike-in control. Data are mean ± s.d. from three biological 407 
replicates. 408 
c, Top: Western analysis of 3xFLAG-Epe1 (endogenous gene tagged) levels before 409 
and after low caffeine treatment. Loading control: a-tubulin. For gel source data, see 410 
Supplementary Figure 1a. 411 
Bottom: Quantification of 3xFLAG-Epe1 protein levels normalized to a-tubulin. Data 412 
are mean ± s.d. from four biological replicates. P value: two-tailed Student’s t-test. 413 
d, Effect of caffeine treatment on association of Epe1 with chromatin. qChIP analysis 414 
of Epe1-GFP levels at sub-telomeric tlh2 locus and centromere 1 (dg repeats: cen-415 
dg; outer boundary: cen-IRC) in wt cells treated with no, low or medium caffeine. 416 
Epe1-GFP levels were normalized to spike-in control. Data are mean ± s.d. from three 417 
biological replicates. 418 
e, Model. Resistant isolates arise following exposure to a lethal insult. Resistance 419 
could be mediated by permanent, DNA-based changes (resistant mutants) or 420 
reversible, heterochromatin-based epimutations (resistant epimutants). Upon insult 421 
removal, resistant epimutants can revert to wild-type (sensitive phenotype) by 422 
disassembling ectopic heterochromatin islands, whereas resistant mutants continue 423 
displaying the mutant phenotype due to the genetic nature of DNA mutations. 424 
  425 
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Methods 426 
Yeast strains and manipulations 427 
Standard methods were used for fission yeast growth, genetics and manipulation36. 428 
S. pombe strains used in this study are described in Supplementary Table 2. 429 
Oligonucleotide sequences are listed in Supplementary Table 3. For pDUAL-adh21-430 
TetR-2xFLAG-Clr4-CDD (abbreviated as TetR-Clr4*), the nmt81 promoter of pDUAL-431 
nmt81-TetR-2xFLAG-Clr4-CDD4, was replaced by the adh21 promoter (pRAD21, gift 432 
from Y. Watanabe). NotI-digested plasmid was integrated at leu1+.  433 
To reduce expression of SPBC17G9.13c+/cup1+ we used two independent strategies. 434 
First, we expressed an additional copy of cup1+ with three nuclear exosome RNA 435 
degradation motifs (DSR; Determinant of Selective Removal37,38) fused to its 3’ 436 
untranslated region from an intergenic locus (LocusPX:cup1-3xDSR). Following 437 
insertion of cup1-3xDSR at LocusPX, endogenous cup1+ was deleted and cells 438 
expressing only cup1-3xDSR were analysed. Second, the 144-bp transcriptional 439 
terminator site from ura4+ was inserted in place of part of the putative cup1+ promoter 440 
(cup1-TT) and cells were analysed. 441 
pap1-N424STOP, clr5-Q264STOP meu27-S100Y, LocusPX:cup1-3xDSR, cup1-TT, 442 
cup1-L73G, cup1-F99G, cup1-GFP, 3xFLAG-epe1 and strains carrying 4xtetO 443 
insertions were constructed by CRISPR/Cas9-mediated genome editing using the 444 
SpEDIT system (Allshire Lab; available on request) with oligonucleotides listed in 445 
Supplementary Table 3. The mitochondrial protein Arg1139, Epe1 and Mst2 were C-446 
terminally tagged with mCherry (Arg11), GFP (Epe1) or 13xMyc (Mst2) using the 447 
Bähler tagging method40.  448 
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Yeast extract plus supplements (YES) was used to grow all cultures. 16 mM caffeine 449 
(Sigma, C0750) was added to media for caffeine resistance screens and serial dilution 450 
assays. To screen for unstable caffeine-resistant isolates, caffeine-resistant colonies 451 
that formed seven days after plating wild-type cells on 16 mM caffeine YES (+CAF) 452 
plates were picked and patched to +CAF plates. After four days of growth, isolates 453 
were frozen (4day/+CAF). 4day/+CAF isolates were re-patched and grown for three 454 
days on +CAF plates and then frozen (7day/+CAF). Subsequently, 7day/+CAF 455 
isolates were re-patched every three days on +CAF plates up to twenty days of total 456 
growth on +CAF plates and then frozen (20day/+CAF).  457 
0.29 µM clotrimazole (Sigma, C6019) was added to media for clotrimazole resistance 458 
serial dilution assays. 1.6 µM tebuconazole (Sigma, 32013) was added to media for 459 
tebuconazole resistance serial dilution assays. 0.6 mM fluconazole (Sigma, PHR1160) 460 
was added to media for fluconazole resistance serial dilution assays.  461 
7 or 14 mM caffeine (Sigma, C0750), or 1 mM hydrogen peroxide (Sigma, H1009) 462 
were added to media for 18 hours for drug treatment experiments. To release TetR-463 
Clr4*, 10 µM anhydrotetracycline (AHT) was added to the media. 464 
Serial dilution assays 465 
Equal amounts of starting cells were serially diluted five-fold and then spotted onto 466 




Chromatin immunoprecipitation (ChIP) 470 
ChIP experiments were performed as previously described41 using anti-H3K9me2 471 
(5.1.1, gift from Takeshi Urano) or anti-GFP (Invitrogen, A11122). 472 
Immunoprecipitated DNA was recovered with Chelex-100 resin (BioRad) for ChIP-473 
qPCR (qChIP) experiments or with QIAquick PCR Purification Kit (Qiagen) for ChIP-474 
seq experiments. 475 
Quantitative ChIP-qPCR (qChIP) 476 
qChIPs were analysed by real-time PCR using Lightcycler 480 SYBR Green (Roche) 477 
with oligonucleotides listed in Supplementary Table 3. All ChIP enrichments were 478 
calculated as % DNA immunoprecipitated at the locus of interest relative to the 479 
corresponding input samples and normalized to % DNA immunoprecipitated at the 480 
act1+ locus. For spike-in qChIPs, an equal number (~20%) of Schizosaccharomyces 481 
octosporus cells (H3K9me2 spike-in qChIP)41 or Sgo1-GFP Saccharomyces 482 
cerevisiae cells (GFP spike-in qChIP)42 (gift from Adele Marston) were added to initial 483 
S. pombe pellets. Histograms represent data averaged over three biological 484 
replicates. Error bars represent standard deviations.  485 
ChIP-seq library preparation and analysis 486 
Illumina-compatible libraries were prepared as previously described41 using 487 
NEXTflex-96 barcode adapters (Bioo Scientific) and Ampure XP beads (Beckman 488 
Coulter). Libraries were then pooled to allow multiplexing and sequenced on an 489 
Illumina HiSeq2000, NextSeq or MiniSeq system (150-cycle high output kit) by 75 bp 490 
paired-end sequencing.  491 
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Approximately 6-10 million 75 bp paired-end reads were produced for each sample. 492 
Raw reads were then de-multiplexed and trimmed using Trimmomatic (v0.35)43 to 493 
remove adapter contamination and regions of poor sequencing quality. Trimmed 494 
reads were aligned to the S. pombe reference genome (972h-, ASM294v2.20) using 495 
Bowtie2 (v2.3.3)44. Resulting bam files were processed using Samtools (v1.3.1)45 and 496 
picard-tools (v2.1.0) (http://broadinstitute.github.io/picard) for sorting, removing 497 
duplicates and indexing. Coverage bigwig files were generated by BamCoverage 498 
(deepTools v2.0) and ratios IP/input were calculated using BamCompare (deepTools 499 
v2.0)46 in SES mode for normalisation47. Peaks were called using MACS248 in PE mode 500 
and broad peak calling (broad-cutoff = 0.05). Region-specific H3K9me2 enrichment 501 
plots were generated using the Sushi R package (v1.22)49. Heatmaps were generated 502 
using computeMatrix and plotHeatmap (deepTools v2.0)46 with genomic coordinates 503 
indicated in Supplementary Table 4. 504 
SNP and indel calling 505 
SNPs and indels were called as previously described50. Trimmed reads were mapped 506 
to the S. pombe reference genome (972h-, ASM294v2.20) using Bowtie2 (v2.3.3)44. 507 
GATK51,52 was used for base quality score recalibration. SNPs and indels were called 508 
with GATK HaplotypeCaller51,52 and filtered using custom parameters. Functional 509 
effect of variants was determined using Variant Effect Predictor53. 510 
Copy number variation analysis 511 
Copy number variation was determined using CNVkit54 in Whole-Genome 512 
Sequencing (-wgs) mode. Wild-type ChIP-seq input bam files were used as reference. 513 
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Extrachromosomal circular DNA diagnostic PCRs and Southern analysis 514 
ChIP-input DNA samples were used as template for PCR with Taq polymerase 515 
(Roche, 4728858001) according to manufacturer’s instructions. Two types of PCR 516 
were performed: control PCR for loci present on endogenous chromosome III 517 
(expected to be present in wild-type, UR-2 (7day/+CAF) and UR-4) and circle-specific 518 
PCRs specific for putative extrachromosomal circles predicted to be present in UR-519 
2 (7day/+CAF) or UR-4. For wild-type and UR-2 (7day/+CAF): control primers were 520 
located on either on side of 5S rRNA.24 (primers A (forward), B (reverse); see 521 
Supplementary Table 3) and 5S rRNA.26 (primers C, D); circle-specific primers were 522 
located on either side of a predicted junction between 5S rRNA.24 and 5S rRNA.26 523 
(primers C and B). For wild-type and UR-4: control primers were located on either on 524 
side of LTR3 (primers E, F) and or LTR27 (primers G, H); circle-specific primers were 525 
located on either side of a predicted junction between LTR3 and LTR27 (primers G 526 
and F). For some locations, more than one forward and/or reverse primer was used, 527 
for instance: forward primers C1, C2 with reverse primers D1, D2. PCR products were 528 
electrophoresed on 2% agarose gels containing Ethidium Bromide. 529 
For Southern analysis, genomic DNA was prepared from wild-type, UR-2 530 
(7day/+CAF) and UR-4 cultures grown in YES. Briefly, cells were incubated with 531 
Zymolyase 100T (AMS Biotechnology) to digest the cell wall, pelleted, resuspended 532 
in TE and lysed with SDS, followed by addition of potassium acetate and precipitation 533 
with isopropanol. After treatment with RNase A and proteinase K, phenol chloroform 534 
and chloroform extractions were performed. DNA was precipitated in the presence 535 
of sodium acetate and ethanol, followed by centrifugation and washing of the pellet 536 
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with 70% ethanol. After air drying the pellet was resuspended in TE. Approximately 8 537 
µg of DNA was digested with the following restriction enzymes: wild-type and UR-2 538 
(7day/+CAF): BsmBI, EcoRV, NdeI; wild-type and UR-4: EcoRI, BamHI + XbaI.  539 
Digested DNA was subjected to electrophoresis in a 0.9 % agarose gel containing 540 
ethidium bromide. Southern blotting was achieved by the alkali transfer method. 541 
Briefly, the gel was depurinated with 0.3 M HCl for 10 minutes, washed with distilled 542 
water, followed by two 15 min incubations in Denaturing Solution (0.5 M NaOH, 1.5 543 
M NaCl). Overnight capillary transfer was used for transfer to Hybond XL membrane 544 
(Amersham), which was then washed with 50 mM Na2HPO4 pH7.2, followed by air 545 
drying. After drying at 80oC for 2 hours and UV-crosslinking, membranes were 546 
prehybridized in Church Buffer (0.5 M Na2HPO4 pH 7.2, 7% SDS, 1 mM EDTA, 1% 547 
BSA (Sigma, A0281) for 1 hour at 65oC. Probes were made using High Prime kit 548 
(Roche, 11585592001) and a-32P-dCTP (NEN), according to the manufacturer’s 549 
instructions.  Heat denatured probes in Church Buffer were hybridized with relevant 550 
membranes at 65oC overnight with rotation. Following washes with Wash Buffer (40 551 
mM Na2HPO4 pH 7.2, 1 mM EDTA, 1% SDS) blots were exposed to XAR-5 film 552 
(Kodak) at -80oC with an intensifying screen for several hours. 553 
Cytology 554 
Schizosaccharomyces pombe cultures were fixed before processing for 555 
immunofluorescence as described41. Briefly, cells in YES culture were fixed with 3.7% 556 
formaldehyde (Sigma, F8775) for 30 min, followed by cell wall digestion with 557 
Zymolyase-100T (AMS Biotechnology) in PEMS buffer (100 mM PIPES pH 7, 1 mM 558 
EDTA, 1 mM MgCl2, 1.2 M Sorbitol). After permeabilization with Triton-X100, cells 559 
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were washed, blocked in PEMBAL (PEM containing 1% BSA, 0.1% sodium azide, 560 
100 mM lysine hydrochloride). Rabbit anti-GFP (Invitrogen, A11122) was used in 561 
PEMBAL at 1:500 dilution, and Alexa 488-coupled chicken-anti-rabbit secondary 562 
antibody (Invitrogen, A21441) at 1:1000 dilution. Arg11-mCherry fluorescence 563 
survived fixation and no antibodies were used for localisation. Cells were stained with 564 
DAPI and mounted in Vectashield. Microscopy was performed with a Zeiss Imaging 565 
2 microscope (Zeiss) using a 100x 1.4NA Plan-Apochromat objective, Prior filter 566 
wheel, illumination by HBO100 mercury bulb. Image acquisition with a Photometrics 567 
Prime sCMOS camera (Photometrics, https://www.photometrics.com) was 568 
controlled using Metamorph software (Version 7; Universal Imaging Corporation). 569 
Exposures were 3000 ms for FITC/Alexa-488 channel (Cup1-GFP/Alexa 488), 500 ms 570 
for TRITC channel (Arg11-mCherry) and 100 ms for DAPI. For display of images, 571 
maximum intensity was determined for e.g. Cup1-GFP staining in Cup1-GFP Arg11-572 
mCherry strain (B4909) and this maximum was applied for scaling of all B4909 and 573 
B4912 (expresses only Arg11-mCherry) images. FITC and TRITC channels were 574 
scaled in this way; DAPI images were autoscaled. 575 
qRT–PCR analysis 576 
Total RNA was extracted using the Monarch Total RNA Miniprep Kit (New England 577 
Biolabs) according to the manufacturer’s instructions. Contaminating DNA was 578 
removed by treating with Turbo DNase (Invitrogen) and reverse transcription was 579 
performed using LunaScript RT Supermix Kit (New England Biolabs). 580 
Oligonucleotides used for qRT-PCR are listed in Supplementary Table 3. qRT-PCR 581 
histograms represent three biological replicates; error bars correspond to the 582 
standard deviation. 583 
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RNA-seq library preparation and analysis 584 
Total RNA was extracted using the Monarch Total RNA Miniprep Kit (New England 585 
Biolabs) according to the manufacturer’s instructions. Contaminating DNA was 586 
removed by treating with Turbo DNase (Invitrogen). rRNA was removed using the 587 
Ribo-Zero Gold rRNA removal kit (Yeast) (Illumina) before library construction using 588 
NEBNext Ultra II Directional RNA Library Prep Kit for Illumina (New England Biolabs). 589 
Libraries were pooled and sequenced on an Illumina NextSeq platform by 75 bp 590 
paired-end sequencing. Adapter-trimmed reads were aligned to the S. pombe 591 
reference genome (972h-, ASM294v2.20) using STAR (v2.2.1)55 and processed using 592 
Samtools (v1.3.1)45. Coverage bigwig files were generated by BamCoverage 593 
(deepTools v2.0)46. 594 
Differential expression was analysed using the Bioconductor Rsamtools (v2.0.3), 595 
GenomicFeatures (v1.36.4)56 and DESeq2 (v.1.24)57 R libraries. Log2 fold changes 596 
were shrunk using the apeglm method58 and a MA-plot was generated using R. Genes 597 
with an adjusted p value below 0.01 are shown in red. 598 
Small RNA-seq 599 
50 mL of log-phase cells were collected and processed using the mirVana miRNA 600 
Isolation kit (Invitrogen). Resulting sRNA was treated with TURBO DNase 601 
(Invitrogen) and used for library construction using NEBNext Multiplex Small RNA 602 
Library Prep Set for Illumina (New England Biolabs) according to manufacturer’s 603 
instructions. Libraries were pooled and sequenced on an Illumina NextSeq platform 604 
by 50 bp single-end sequencing. Raw reads were then de-multiplexed and 605 
processed using Cutadapt (v1.17) to remove adapter contamination and discard 606 
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reads shorter than 19 nucleotides or longer than 25 nucleotides. Coverage plots were 607 
generated using SCRAM59. 608 
Protein extraction and western analysis 609 
Protein samples were prepared as previously detailed60. Western blotting detection 610 
was performed using anti-FLAG-HRP (Sigma, A8591), anti-Myc (Cell Signalling, 611 
9B11), anti-a-tubulin (gift from Keith Gull)61, goat anti-mouse (Sigma, A4416), anti-612 
Bip162, goat anti-rabbit (Sigma, A6154), anti-Cdc11 (gift from Ken Sawin) and donkey 613 
anti-sheep (Abcam, ab6900). Gels were visualised using the ChemiDoc imaging 614 
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Extended Data Figure 1. Identification of heterochromatin-dependent 737 
epimutants resistant to caffeine 738 
a, Frequency of unstable (UR) and stable (SR) caffeine-resistant isolates obtained 739 
from 3 independent screens. 64% of isolates did not display a clear phenotype 740 
(unclear). 741 
b, Unstable (UR) and stable (SR) caffeine-resistant isolates were identified using this 742 
screening strategy. After growth on non-selective media for 14 days caffeine 743 
resistance is lost in UR isolates but not in SR isolates.  744 
c, Caffeine resistance is lost progressively in unstable (UR) isolates but maintained in 745 
stable (SR) isolates. 746 
d, Caffeine resistance in UR isolates depends on the Clr4 H3K9 methyltransferase. 747 
clr4+ (clr4Δ) or an unlinked intergenic region (controlΔ) were deleted in unstable (UR-748 
2) and stable (SR-2) caffeine-resistant isolates. 749 
e, A mutation in pap1+ confers caffeine resistance in the stable isolate SR-1. Left: 750 
Whole genome sequencing of the stable isolate SR-1 revealed a 7-nucleotide 751 
insertion in pap1+. The insertion results in a truncated Pap1 protein (Pap1-N424STOP) 752 
that lacks the Nuclear Export Signal (NES). CRD: Cysteine-rich domain. Right: Pap1-753 
N424STOP is resistant to caffeine. The 7-nucleotide insertion identified in SR-1 was 754 
introduced into the pap1+ gene of wild-type cells (Pap1-N424STOP) and caffeine 755 
resistance assessed. hba1Δ and SR-1 cells were used as positive controls.  756 
Experiments in (b-d) and (e, right) were independently repeated at least twice with 757 










Extended Data Figure 2. Unstable (UR) caffeine-resistant isolates are bona fide 767 
epimutants. 768 
a-e, Genetic changes (clr5-Q264STOP meu27-S100Y) found in 4 of 30 unstable 769 
isolates do not contribute to the caffeine-resistant phenotype nor cause the formation 770 
of ectopic heterochromatin. 771 
a, Whole genome sequencing of unstable isolates UR-1/3/5/7 revealed a Single 772 
Nucleotide Polymorphism (SNP) in clr5+ (clr5-Q264STOP) and in meu27+ (meu27-773 
S100Y). 774 
b, Left: Schematic of experiment to determine whether clr5-Q264STOP meu27-775 
S100Y cells form more caffeine-resistant colonies than wild-type cells. Wild-type (wt) 776 
and clr5-Q264STOP meu27-S100Y cells were plated on +CAF media (105 cells per 777 
plate, 20 plates per strain). Caffeine-resistant colonies were counted after 7 days. 778 
Right: clr5-Q264STOP meu27-S100Y form a similar number of caffeine-resistant 779 
colonies to wt cells. Data are mean from twenty technical replicates. P value from a 780 
two-tailed Student’s t-test is indicated. 781 
c, clr5-Q264STOP meu27-S100Y cells are not resistant to caffeine. clr5-Q264STOP 782 
meu27-S100Y cells were serially diluted and spotted on -CAF and +CAF plates to 783 
assess caffeine resistance. hba1Δ cells served as a positive control. Experiment was 784 
independently repeated at least twice with similar results. 785 
d, Genome-wide H3K9me2 ChIP-seq enrichment in wt and clr5-Q264STOP meu27-786 
S100Y cells. Data are represented as relative fold enrichment over input. 787 
e, H3K9me2 ChIP-seq enrichment at known heterochromatin islands detected in 788 
epe1Δ cells9 in wt and clr5-Q264STOP meu27-S100Y cells. Data are represented as 789 
relative fold enrichment over input. 790 
f, Gene transcript levels within and flanking ectopic heterochromatin islands in 791 
individual isolates. See Figure 2b. Data are mean ± s.d. from three biological 792 






Extended Data Figure 3. 24 of 30 unstable (UR) caffeine-resistant isolates 798 
display an ectopic heterochromatin island over the ncRNA.394 locus 799 
a, H3K9me2 ChIP-seq enrichment at the ncRNA.394 locus in individual isolates (left: 800 
coverage tracks; right: heatmaps). Data are represented as relative fold enrichment 801 
over input. Relevant genes within and flanking ectopic heterochromatin islands are 802 
indicated. Red arrows indicate essential genes. Dumbbells indicate primer pairs used 803 
in b, c and e. 804 
b, Quantitative chromatin immunoprecipitation (qChIP) of H3K9me2 levels on 805 
ncRNA.394 in individual isolates. Data are mean ± s.d. from three biological 806 
replicates. Primer pairs used are indicated in a (ncRNA.394, primer pair 5). 807 
c, SPBC17G9.13c+ gene transcript levels in individual isolates. Data are mean ± s.d. 808 
from three biological replicates. P values from a two-tailed Student’s t-test are 809 
indicated. Primer pairs used are indicated in a (SPBC17G9.13c+, primer pair 3). 810 
d, Deletion of ncRNA.394 or non-essential adjacent genes does not result in caffeine 811 
resistance. Experiment was independently repeated at least twice with similar results. 812 
e, qChIP of H3K9me2 levels at the ncRNA.394 locus in UR-2 cells. UR-2 cells were 813 
grown in the absence (-CAF) or presence (+CAF) of caffeine overnight or in the 814 
absence of caffeine for 14 days (+14day/-CAF). Data are mean ± s.d. from three 815 














Extended Data Figure 4. Forced synthetic heterochromatin targeting to the 829 
identified loci is sufficient to drive caffeine resistance in wild-type cells 830 
a-c, Quantitative chromatin immunoprecipitation (qChIP) of H3K9me2 levels in wild-831 
type (wt) cells harbouring 4xtetO binding sites at the identified ectopic 832 
heterochromatin loci (or ura4 as control) and expressing TetR-Clr4* in the absence or 833 
presence of AHT. a, hba1 locus. b, ncRNA.394 locus. c, ura4 locus. Data are mean ± 834 
s.d. from three biological replicates. Dumbbells indicate primer pairs used. Red 835 
arrows indicate essential genes. 836 
d, Forced synthetic heterochromatin targeting to the mbx2 locus is sufficient to drive 837 
caffeine resistance in wt cells. qChIP of H3K9me2 levels in wt cells harbouring 4xtetO 838 
binding sites at the mbx2 ectopic heterochromatin locus and expressing TetR-Clr4* 839 
in the absence or presence of AHT. Data are mean ± s.d. from three biological 840 
replicates. Dumbbells indicate primer pairs used. 841 
e, Strains from a-c were assessed for resistance to the antifungal agents 842 
tebuconazole (+TEZ) and fluconazole (+FLZ). Experiments were independently 843 
















Extended Data Figure 5. Unstable (UR) caffeine-resistant isolates show cross-859 
resistance to antifungals and siRNA generation at ectopic heterochromatin 860 
islands 861 
a, Unstable caffeine-resistant isolates UR-1 and UR-2 were serially diluted and 862 
spotted on non-selective (N/S), caffeine (+CAF), clotrimazole (+CLZ), tebuconazole 863 
(+TEZ) and fluconazole (+FLZ) media to assess resistance. Experiment was 864 
independently repeated at least twice with similar results. 865 
b-c, Left: small RNA sequencing detects siRNAs (21-24 nucleotides) homologous to 866 
ectopic heterochromatin islands in UR-1 (b, hba1 locus) and UR-2 (c, ncRNA.394 867 
locus) compared to wild-type (wt) cells. Right: siRNAs mapping to pericentromeric 868 
dgI/dhI repeats of chromosome I shown as control. Sequencing was performed once. 869 
*Transcripts mapping to the highly-expressed gene eno101+ in euchromatic wild-type 870 
conditions (note these are unidirectional RNAs and not siRNAs). 871 
d, Caffeine resistance depends on RNAi. dcr1+ (dcr1Δ), ago1+ (ago1Δ) or an unlinked 872 
intergenic region (controlΔ) were deleted in UR-2 cells. Experiment was 873 














  888 
 38 
Extended Data Figure 6. Decreased cup1+ transcript levels or Cup1 LYR-domain 889 
mutation results in caffeine resistance 890 
a, An additional copy of cup1+ with 3x Determinant of Selective Removal (DSR) motifs 891 
fused to its 3’ untranslated region was inserted at an intergenic region 892 
(LocusPX:cup1-3xDSR). Bottom left: After deletion of endogenous cup1+, cells 893 
expressing only cup1-3xDSR were assessed for caffeine resistance. Bottom right: 894 
Transcript levels of cup1+ and SPBC17G9.12c+ (as control) in cup1Δ locusPX:cup1-895 
3xDSR cells compared to wild-type. Data are mean ± s.d. from three biological 896 
replicates. P value from a two-tailed Student’s t-test is indicated. Dumbbells indicate 897 
primer pairs used.  898 
b, The 144-bp transcriptional terminator site from ura4+ was inserted in place of part 899 
of the putative cup1+ promoter (cup1-TT). Bottom left: Cells were assessed for 900 
caffeine resistance. Bottom right: Transcript levels of cup1+ and SPBC17G9.12c+ (as 901 
control) in cup1-TT cells compared to wild type. Data are mean ± s.d. from three 902 
biological replicates. P value from a two-tailed Student’s t-test is indicated. 903 
Dumbbells indicate primer pairs used. 904 
c, Cup1 localises to mitochondria. Cells expressing either untagged Cup1 (top row) 905 
or Cup1-GFP (bottom three rows) were fixed and processed for immunofluorescence 906 
with anti-GFP antibody and Alexa-488 secondary antibody and DNA was stained with 907 
DAPI. The mitochondrial protein Arg11-mCherry served as a positive control for 908 
mitochondrial localisation. All images in the green channel (Cup1-GFP) are scaled 909 
relative to each other, as are those in the red channel (Arg11-mCherry); DAPI images 910 
are autoscaled. Bar, 5 µm.  911 
d, Point mutations (L73G and F99G) were introduced in the LYR domain of Cup1 and 912 
cells were assessed for caffeine resistance. Mutations were designed based on 913 
Phyre2 tool analysis. hba1Δ cells were used as positive control.  914 
Experiments in (c) and (d) were independently repeated at least twice with similar 915 






Extended Data Figure 7. Copy Number Variation (CNV) analysis reveals a partial 921 
duplication of chromosome III in 12 of 30 unstable (UR) caffeine-resistant 922 
isolates 923 
a, Chromosome III coverage plots with overlaid segments in UR isolates showing 924 
partial duplication of chromosome III. Location of cds1+ is highlighted. Wild-type 925 
ChIP-seq input data were used as the reference. 926 
b-d, Epigenetic changes preceded genetic changes (CNV) in unstable caffeine-927 
resistant isolate UR-2. 928 
b, H3K9me2 ChIP-seq enrichment at the ncRNA.394/cup1 locus (left) and 929 
chromosome III coverage plots with overlaid segments (right) in UR-2 (4day/+CAF) 930 
cells and following their prolonged growth on +CAF for an additional 3 days 931 
(7day/+CAF). Wild-type ChIP-seq input data were used as the reference for CNV 932 
analysis. 933 
c, clr4+ (clr4Δ) or an unlinked intergenic region (controlΔ) were deleted in UR-2 cells 934 
(4day/+CAF) and UR-2 (7day/+CAF). All (6/6) UR-2 (4day/+CAF) clr4Δ transformants 935 
lost resistance to caffeine whereas only 50% (3/6, transformants 1, 4 and 5) UR-2 936 
(7day/+CAF) lost resistance to caffeine. Experiments were independently repeated at 937 
least twice with similar results. cds1+ DNA levels in extracted genomic DNA were 938 
assessed by qPCR. Data are mean ± s.d. from three biological replicates.  939 
d, H3K9me2 ChIP-seq enrichment at the ncRNA.394/cup1 locus (left) and 940 
chromosome III coverage plots with overlaid segments (right) in UR-2 (7day/+CAF) 941 
cells and following their prolonged growth on non-selective media for 14 days 942 
(7day/+CAFà14day/-CAF). Wild-type ChIP-seq input data were used as the 943 
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Extended Data Figure 8. Copy Number Variation (CNV) of chromosome III 953 
corresponds to extrachromosomal circular DNA (eccDNA) 954 
Junctions of putative extrachromosomal circles were identified at repetitive 955 
sequences by inspection of CNV plots for UR-2 (7day/+CAF) (a) and UR-4 (b). Maps 956 
and lower panels: Positions of 5S rRNA.24 and 5S rRNA.26 (pink arrows), LTR3 and 957 
LTR27 (green arrows) and flanking genes are indicated. PCR primers (half arrows) 958 
flanking 5S rRNA.24 (A (forward); B1,2 (reverse)) and 5S rRNA.26 (C1,2; D1,2) were 959 
used to amplify products from wild-type (wt) and UR-2 (7day/+CAF) ChIP input 960 
samples, along with primer combinations (C1,2; B1,2) specific for the putative circle 961 
junctions (vertical black lines). Primers flanking LTR3 (E; F1,2) and LTR27 (G1,2; H) 962 
were used to amplify products from wild-type and UR-4 ChIP input samples, along 963 
with primer combinations (G1,2; F1,2) specific for the putative circle junction. Shaded 964 
boxes indicate primer locations and predicted circle junctions (pink: 5S rRNA.24/26, 965 
green: LTR3/27). Right: Restriction enzyme-digested genomic DNA isolated from 966 
wild-type (wt), UR-2 (7day/+CAF) and UR-4 was separated on an Ethidium Bromide 967 
(EtBr)-containing gel followed by Southern analysis using the indicated probes (925: 968 
blue; 520: purple; 44: red). Relevant restriction enzyme sites are indicated. Predicted 969 
sizes of hybridising fragments and DNA size markers are indicated (kb). PCR 970 
experiments were independently repeated at least twice with similar results. For gel 971 














Extended Data Figure 9. The heterochromatin profile of low caffeine-treated 985 
wild-type cells resembles that of untreated epe1Δ cells 986 
a, Growth of cells in caffeine. Wild-type (wt) cells were grown in the presence of low 987 
(7 mM) or medium (14 mM) caffeine for 18 hours. Cell number was counted every 6 988 
hours. Note: a larger inoculum was used for 14 mM caffeine culture to obtain an 989 
equivalent final number of cells. Data are mean ± s.d. from three biological replicates.  990 
Cells from the 18-hr time point were used for d.  991 
b-c, H3K9me2 ChIP-seq enrichment at previously-detected facultative 992 
heterochromatin loci (described in Zofall et al., 20129 (b and c), Yamanaka et al., 993 
201313 (b), Wang et al., 201510 (b), Sorida et al., 201912 (b) and Gallagher et al., 201914 994 
(b)), in wt cells treated with low or medium dose of caffeine or low dose (1 mM) of 995 
H2O2, compared to untreated epe1Δ and wt cells. Data are represented as relative 996 
fold enrichment over input. A subset of facultative heterochromatin loci detected in 997 
untreated epe1Δ cells (Zofall et al., 20129, Wang et al., 201510 and Sorida et al., 201912) 998 
was detected in low caffeine-treated wt cells. Asterisks in c indicate loci with similar 999 
H3K9me2 patterns in low caffeine-treated wt cells and untreated epe1Δ cells, but not 1000 
untreated wt cells. Facultative heterochromatin loci formed in the absence of the 1001 
exosome (Yamanaka et al., 201313) or in wt cells grown at 18oC (Gallagher et al., 1002 
201914) were not detected in wt cells treated with low or medium caffeine or low H2O2.  1003 
d, Quantitative ChIP (qChIP) of H3K9me2 levels on ncRNA.394/cup1 in wt cells 1004 
following 18 hr exposure to low or medium caffeine. H3K9me2 levels were normalized 1005 
to S. octosporus spike-in control. Data are mean ± s.d. from three biological 1006 
replicates. 1007 
e, H3K9me2 ChIP-seq enrichment at ncRNA.394/cup1 and mcp7 loci (or at 1008 
pericentromeric dgI/dhI repeats of chromosome I as control) in wt cells following 18 1009 
hr exposure to low H2O2. Data are represented as relative fold enrichment over input. 1010 
Red arrows indicate essential genes. Lower levels of H3K9me2 at pericentromeric 1011 
repeats upon H2O2 treatment may be due to H2O2-specific regulation of limiting 1012 
heterochromatin factors at this locus. 1013 
f, epe1+ RNA levels do not change upon caffeine treatment. Total RNA-seq of wt cells 1014 
treated with low caffeine. Components of the Clr4 H3K9 methyltransferase CLRC 1015 
complex (clr4+, rik1+, raf1+, raf2+, pcu4+ and rbx1+) and the antisilencing factors epe1+ 1016 
 42 
and mst2+ are highlighted. Experiment was independently repeated twice with similar 1017 
results.  1018 
g, epe1Δ cells display increased resistance to caffeine. Left: Schematic of 1019 
experiment. Wild-type, epe1Δ and clr4Δ cells were plated on +CAF media (105 1020 
cells/plate, 40 plates/strain). Caffeine-resistant colonies were counted after 7 days. 1021 
Right: Compared to wt cells, epe1Δ forms more, whereas clr4Δ forms fewer, caffeine-1022 
resistant colonies. Note that the total number of resistant colonies also includes 1023 
genetic mutants. Data are mean from forty technical replicates. P values from a two-1024 
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Extended Data Figure 10. A shortened version of the anti-silencing factor Mst2 1036 
is produced upon exposure to caffeine 1037 
a, Western analysis of Mst2-13xMyc (left) and Gcn5-13xMyc (as HAT control, right) 1038 
before and after caffeine treatment (medium concentration, 14 mM). Tagged proteins 1039 
are expressed from their endogenous loci. Loading controls: left: Bip1; right: Cdc11. 1040 
Experiments were independently repeated at least twice with similar results. For gel 1041 
source data, see Supplementary Figure 1c. 1042 
b, Total RNA-seq for mst2 (left) and gcn5 (as HAT control, right) of untreated wild-1043 
type cells (top) or wild-type cells treated with medium caffeine concentration 1044 
(bottom). Diagrams illustrate mst2 and gcn5 transcripts and predicted protein 1045 
domains. Reads are normalized to RPKM. Red dashed lines indicate the region of full 1046 
length mst2 transcript absent from the short isoform. The MYST zinc finger (ZnF) 1047 
domain, required for S. cerevisiae Esa1 acetyltransferase activity29, is truncated in the 1048 
short isoform of Mst2. The alternative mst2 TSS utilised in caffeine conditions was 1049 
previously annotated28. Experiment was independently repeated twice with similar 1050 
results. 1051 
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Supplementary Figure 1. a, Source gel data for Fig. 4c. b, Source gel data for Extended Data Fig. 8. 













































































































































































































Supplementary Table 1. Summary of epigenetic (H3K9me2 domains) and genetic (SNPs, 
indels and copy number variation) changes found in unstable (UR) caffeine-resistant isolates. 
 
Isolate Ectopic heterochromatin location SNPs or indels in coding sequences? 
Partial duplication of 
Chr III? 
 ncRNA.394 other loci   
UR-1  ✓ (hba1) Clr5-Q264STOP / Meu27-S100Y  
UR-2 ✓  Sdo1-R11C  
UR-3  ✓ (ppr4) Clr5-Q264STOP / Meu27-S100Y  
UR-4  ✓ (grt1) - ✓ 
UR-5  ✓ (fio1) Clr5-Q264STOP / Meu27-S100Y ✓ 
UR-6  ✓ (mbx2) - ✓ 
UR-7  ✓ (ppr4) Clr5-Q264STOP / Meu27-S100Y  
UR-8 ✓  -  
UR-9 ✓  -  
UR-10 ✓  Cob1-F318L  
UR-11 ✓  -  
UR-12 ✓  -  
UR-13 ✓  - ✓ 
UR-14 ✓  Npp-W300STOP / SPBC16H5.13-S1011L ✓ 
UR-15 ✓  - ✓ 
UR-16 ✓  -  
UR-17 ✓  SPCC777.02-R120R ✓ 
UR-18 ✓  SPCC777.02-R120R ✓ 
UR-19 ✓  Sdo1-R11C ✓ 
UR-20 ✓  -  
UR-21 ✓  - ✓ 
UR-22 ✓  - ✓ 
UR-23 ✓  Pch1-Q234STOP  
UR-24 ✓  -  
UR-25 ✓  - ✓ 
UR-26 ✓  SPBC1271.08c-A133A  
UR-27 ✓  SPCC4B3.13-A229V  
UR-28 ✓  Mug72-N116S  
UR-29 ✓  Mug72-N116S  




Supplementary Table 2. Schizosaccharomyces pombe strains used in this study.  
 
Strain number Name Description 
143 wt h- ED972 wild-type 
B4411 SR-1 Stable 16 mM Caffeine Resistant Isolate – From wt – 1  
B4412 SR-2 Stable 16 mM Caffeine Resistant Isolate – From wt – 2 
B4413 UR-1 Unstable 16 mM Caffeine Resistant Isolate – From wt – 1  
B4414 UR-2 Unstable 16 mM Caffeine Resistant Isolate – From wt – 2 
B4415 UR-3 Unstable 16 mM Caffeine Resistant Isolate – From wt – 3  
B4416 UR-4 Unstable 16 mM Caffeine Resistant Isolate – From wt – 4 
B4417 UR-5 Unstable 16 mM Caffeine Resistant Isolate – From wt – 5  
B4418 UR-6 Unstable 16 mM Caffeine Resistant Isolate – From wt – 6  
B4419 UR-7 Unstable 16 mM Caffeine Resistant Isolate – From wt – 7  
B4420 UR-8 Unstable 16 mM Caffeine Resistant Isolate – From wt – 8  
B4421 UR-9 Unstable 16 mM Caffeine Resistant Isolate – From wt – 9  
B4422 UR-10 Unstable 16 mM Caffeine Resistant Isolate – From wt – 10  
B4423 UR-11 Unstable 16 mM Caffeine Resistant Isolate – From wt – 11  
B4424 UR-12 Unstable 16 mM Caffeine Resistant Isolate – From wt – 12  
B4425 UR-13 Unstable 16 mM Caffeine Resistant Isolate – From wt – 13  
B4426 UR-14 Unstable 16 mM Caffeine Resistant Isolate – From wt – 14  
B4427 UR-15 Unstable 16 mM Caffeine Resistant Isolate – From wt – 15 
B4428 UR-16 Unstable 16 mM Caffeine Resistant Isolate – From wt – 16  
B4429 UR-17 Unstable 16 mM Caffeine Resistant Isolate – From wt – 17  
B4430 UR-18 Unstable 16 mM Caffeine Resistant Isolate – From wt – 18  
B4431 UR-19 Unstable 16 mM Caffeine Resistant Isolate – From wt – 19  
B4432 UR-20 Unstable 16 mM Caffeine Resistant Isolate – From wt – 20  
B4433 UR-21 Unstable 16 mM Caffeine Resistant Isolate – From wt – 21  
B4434 UR-22 Unstable 16 mM Caffeine Resistant Isolate – From wt – 22  
B4435 UR-23 Unstable 16 mM Caffeine Resistant Isolate – From wt – 23  
B4436 UR-24 Unstable 16 mM Caffeine Resistant Isolate – From wt – 24  
B4437 UR-25 Unstable 16 mM Caffeine Resistant Isolate – From wt – 25  
B4438 UR-26 Unstable 16 mM Caffeine Resistant Isolate – From wt – 26  
B4439 UR-27 Unstable 16 mM Caffeine Resistant Isolate – From wt – 27  
B4440 UR-28 Unstable 16 mM Caffeine Resistant Isolate – From wt – 28  
B4441 UR-29 Unstable 16 mM Caffeine Resistant Isolate – From wt – 29  
B4442 UR-30 Unstable 16 mM Caffeine Resistant Isolate – From wt – 30  
B4443 SR-1 clr4Δ - 1 SR-1 clr4Δ::NAT - transformant 1 
B4444 SR-1 clr4Δ - 2 SR-1 clr4Δ::NAT - transformant 2 
B4445 SR-1 NAT control - 1 SR-1 NAT:3’ of ura4 - transformant 1 
B4446 SR-1 NAT control - 2 SR-1 NAT:3’ of ura4 - transformant 2 
B4447 SR-2 clr4Δ - 1 SR-2 clr4Δ::NAT - transformant 1 
B4448 SR-2 clr4Δ - 2 SR-2 clr4Δ::NAT - transformant 2 
B4449 SR-2 NAT control - 1 SR-2 NAT:3’ of ura4 - transformant 1 
B4450 SR-2 NAT control - 2 SR-2 NAT:3’ of ura4 - transformant 2 
B4451 UR-1 clr4Δ - 1 UR-1 clr4Δ::NAT - transformant 1 
B4452 UR-1 clr4Δ - 2 UR-1 clr4Δ::NAT - transformant 2 
B4453 UR-1 NAT control-1 UR-1 NAT:3’ of ura4 - transformant 1 
B4454 UR-1 NAT control-2 UR-1 NAT:3’ of ura4 - transformant 2 
B4455 UR-2 clr4Δ - 1 UR-2 clr4Δ::NAT - transformant 1 
B4456 UR-2 clr4Δ - 2 UR-2 clr4Δ::NAT - transformant 2 
B4457 UR-2 NAT control - 1 UR-2 NAT:3’ of ura4 - transformant 1 
B4458 UR-2 NAT control - 2 UR-2 NAT:3’ of ura4 - transformant 2 
B5022 UR-2 dcr1Δ - 1 UR-2 dcr1Δ::NAT - transformant 1 
B5023 UR-2 dcr1Δ - 2 UR-2 dcr1Δ::NAT - transformant 2 
B5024 UR-2 ago1Δ - 1 UR-2 ago1Δ::NAT - transformant 1 
B5025 UR-2 ago1Δ - 2 UR-2 ago1Δ::NAT - transformant 2 
B4352 Pap1-N424STOP h- pap1-N424STOP 
B4752 Clr5-Q264STOP Meu27-S100Y h- clr5-Q264STOP meu27-S100Y 
B4459 UR-2 (+14day/-CAF) UR-2 after growth on -CAF media for 14 days 
B4460 hba1Δ h- hba1Δ::NAT 
B4461 SPBC17G9.12cΔ h- SPBC17G9.12cΔ::NAT 
B4462 ncRNA.393Δ h- ncRNA.393Δ::NAT 
B4463 ncRNA.394Δ h- ncRNA.394Δ::NAT 
B4464 eno101Δ h- eno101Δ::NAT 
B3797 TetR-Clr4* h+ leu1+adh21-TetROFF-2xFLAG-Clr4-cdd 
B3808 4xtetO-II h- 4xtetO 3' of SPBC17G9.13c leu1-32 
B3813 4xtetO-I h- 4xtetO 5' of hba1 leu1-32 
B3820 4xtetO-III h- 4xtetO 5' of ura4 leu1-32 
B4707 4xtetO-IV h- 4xtetO 5' of mbx2 
B4465 TetR-Clr4* + 4xtetO-II h+ leu1+adh21-TetROFF-2xFLAG-Clr4-cdd 4xtetO 3' of SPBC17G9.13c 
B4466 TetR-Clr4* + 4xtetO-I h+ leu1+adh21-TetROFF-2xFLAG-Clr4-cdd 4xtetO 5' of hba1 
B4467 TetR-Clr4* + 4xtetO-III h+ leu1+adh21-TetROFF-2xFLAG-Clr4-cdd 4xtetO 5' of ura4 
B4807 TetR-Clr4* + 4xtetO-IV h+ leu1+adh21-TetROFF-2xFLAG-Clr4-cdd 4xtetO 5' of mbx2 
B4885 cup1-3xDSR h- cup1Δ LocusPX:cup1-3xDSR (cup1=SPBC17G9.13c) 
B5005 cup1-TT h- cup1-TT (cup1=SPBC17G9.13c) 
B4688 Cup1-L73G h- cup1-L73G (cup1=SPBC17G9.13c) 
B4690 Cup1-F99G h- cup1-F99G (cup1=SPBC17G9.13c) 
B4567 Cup1-GFP h- cup1-GFP (cup1=SPBC17G9.13c) 
B4909 Cup1-GFP Arg11-mCh h- cup1-GFP arg11-mCherry-NAT (cup1=SPBC17G9.13c) 
B4912 Arg11-mCherry h- arg11-mCherry-NAT 
B4468 UR-2 (7day/+CAF) UR-2 after growth on +CAF media for 3 days 
B4469 UR-2 (7day/+CAF              
à14day/-CAF) 
UR-2 after growth on +CAF media for 3 days and then on -CAF 
media for 14 days 
B4621 epe1Δ h- epe1Δ 
B2835 Epe1-GFP h- epe1-GFP-KAN 
B4958 3xFLAG-Epe1 h- 3xFLAG-epe1 
B4767 TetR-Clr4* + 4xtetO-III epe1Δ 
h+ epe1Δ::NAT leu1+adh21-TetROFF-2xFLAG-Clr4-cdd 4xtetO 5' 
of ura4 
B1008 clr4Δ h- clr4Δ::NAT 
B3250 S. cerevisiae Sgo1-GFP S. cerevisiae SGO1-yeGFP::KanMX6 MATa, ade2-1, leu2-3, ura3, trp1-1, his3-11, 15, can1-100, GAL, psi+ 
B3111 S. octosporus wt h90 S. octosporus wild-type 
B4108 Mst2-13xMyc h- mst2-13xMyc-NAT 












Supplementary Table 3. Oligonucleotides used in this study.  
 
Name Sequence Description 
qAct1-F GGTTTCGCTGGAGATGATG qPCR act1+ - F 
qAct1-R ATACCACGCTTGCTTTGAG qPCR act1+ - R 
qDg-F AATTGTGGTGGTGTGGTAATAC qPCR dg repeats - F 
qDg-R GGGTTCATCGTTTCCATTCAG qPCR dg repeats - R 
ST-52 GAATTGTGGAGCCATGTCCC qPCR slu7+ - F 
ST-53 TCTTCTCCTGTCCAACGAGC qPCR slu7+ - R 
ST-872 GAAACCCAGAAATTCGCAGGT qPCR kin17+ - F - primer pair 1 hba1 locus 
ST-873 ATGAGTTGCTTGGGCATCCA qPCR kin17+ - R - primer pair 1 hba1 locus 
ST-62 CAGCAAATTGGGGACTGTGT qPCR ish1+ - F - primer pair 2 hba1 locus 
ST-63 CTCAAGAAGCCTGGGAGTCA qPCR ish1+ - R - primer pair 2 hba1 locus 
ST-64 CGATGATCTGGTTGTATGGTGG qPCR hba1+ - F - primer pair 3 hba1 locus 
ST-65 TGCTCAGTACGCCATCTTGA qPCR hba1+ - R - primer pair 3 hba1 locus 
ST-66 GGGCTATCCTTAACGCTCTTC qPCR hba1+cds - F - primer pair 4 hba1 locus 
ST-67 CGCCTCCTCTGAACCAAAAG qPCR hba1+cds - R - primer pair 4 hba1 locus 
ST-58 CTTCCCACATCGCGTTCATT qPCR alp4+ - F - primer pair 5 hba1 locus 
ST-59 ACCTAAATCATCGCTGCTGG qPCR alp4+ - R - primer pair 5 hba1 locus 
ST-393 GGGCATGACAATCTCCGACT qPCR pyr1+ - F - primer pair 1 ncRNA.394 locus 
ST-394 GGCCTACCTCGGTGATCTTG qPCR pyr1+ - R - primer pair 1 ncRNA.394 locus 
ST-401 CCGTATGGTGAAGCAGGGTT qPCR SPBC17G9.12c+ - F - primer pair 2 ncRNA.394 locus 
ST-402 CCCGATCTCCGTGTAAGCAA qPCR SPBC17G9.12c+ - R - primer pair 2 ncRNA.394 locus 
ST-184 TTCGTCGTATGCCCTCTTGC qPCR SPBC17G9.13c+ - F - primer pair 3 ncRNA.394 locus 
ST-185 AAAATCCGCCATTTGCCCAG qPCR SPBC17G9.13c+ - R - primer pair 3 ncRNA.394 locus 
ST-251 TGCTGTAGTGATGCAGAGGAG qPCR ncRNA.393+ - F - primer pair 4 ncRNA.394 locus 
ST-252 GCGGCCATTTTGTTTACATTCC qPCR ncRNA.393+ - R - primer pair 4 ncRNA.394 locus 
ST-190 GAAAATTAGCGCGGCCGTTA qPCR ncRNA.394+ - F - primer pair 5 ncRNA.394 locus 
ST-191 TCAATCTGCTTGTCCCACCC qPCR ncRNA.394+ - R - primer pair 5 ncRNA.394 locus 
ST-263 GTGCTGCCCAAAAGAAGCTC qPCR eno101+ - F - primer pair 6 ncRNA.394 locus 
ST-264 TGGGAACCACCGTTCAAGAC qPCR eno101+ - R - primer pair 6 ncRNA.394 locus 
ST-249 AGCTTTCAAGGTAGCGGGTG qPCR cut2+ - F 
ST-250 TTCCTCTGCTCAGCGTAGAC qPCR cut2+ - R 
PA-354 CAGTTAGTTTCAGGTTTCCC qPCR +2.5 kb ura4+ - F - primer pair 1 ura4 locus 
PA-355 GCAGAGTAATGGTGATTGG qPCR +2.5 kb ura4+ - R - primer pair 1 ura4 locus 
ST-874 CACACAGTTTCAGAAGAAC qPCR tam14+ - F - primer pair 2 ura4 locus 
ST-875 GTTACGAGGAATCTTGGTAG qPCR tam14+ - R - primer pair 2 ura4 locus 
ST-796 CGCGACTGACAAGTTGCTTT qPCR ura4+ - F - primer pair 3 ura4 locus 
ST-797 AGCTAGAGCTGAGGGGATGA qPCR ura4+ - R - primer pair 3 ura4 locus 
ST-800 TGGTTTAAATCAAATCTTCCATGCG qPCR 5’ of ura4+ - F - primer pair 4 ura4 locus 
ST-801 TGAGCAAACTGCTTTTGTGGT qPCR 5’ of ura4+ - R - primer pair 4 ura4 locus 
ST-788 GGATGAAGCTGTCTCCCTGG qPCR new25+ - F - primer pair 5 ura4 locus 
ST-789 TATTGCTGCTTCTTCCCTGGC qPCR new25+ - R - primer pair 5 ura4 locus 
ST-876 GGAATCTATGTCGTTGCCG qPCR pmp20+ - F - primer pair 6 ura4 locus 



































































































































KO of ncRNA.394+ with Bahler construct - F 































Golden Gate cloning 4xtetO-I-sgRNA-R 





Making 4tetO-I-HR-template - 1R 
ST-734 TGATTTCAATACGGcaaggcctactagtgcatgca Making 4tetO-I-HR-template - 2F 





Making 4tetO-I-HR-template - 3F 










Golden Gate cloning 4xtetO-II-sgRNA-R 
ST-720 TTGAATTAATTCATAGAGTATGATAAAAATTGATAGTAAATTCATTGG Making 4tetO-II-HR-template - 1F 
ST-721 cactagtaggccttgATGCATGCTAATAAATCATCGTAACTCAAGTAG Making 4tetO-II-HR-template – 1R 
ST-722 TTTATTAGCATGCATcaaggcctactagtgcatgca Making 4tetO-II-HR-template – 2F 





Making 4tetO-II-HR-template - 3F 










Golden Gate cloning 4xtetO-III-sgRNA-R 





Making 4tetO-III-HR-template – 1R 
ST-746 CTAAAACATCTTAATTATAcaaggcctactagtgcatgca Making 4tetO-III-HR-template – 2F 
ST-747 TTTGCACTTTGTGAATctggatttcgttt acctcaccacca Making 4tetO-III-HR-template – 2R 
ST-748 gtaaacgaaatccagATTCACAAAGTGC AAACATTATCATGAAAAAGAAC Making 4tetO-III-HR-template – 3F 










Golden Gate cloning 4xtetO-IV-sgRNA-R 
ST-836 CTCAACAAACCACTGGTTACATGGC Making 4tetO-IV-HR-template – 1F 
ST-837 actagtaggccttgGATACTTCGCAAAATTCTAAGCATGGTGC Making 4tetO-IV-HR-template – 1R 
ST-838 TTTGCGAAGTATCcaaggcctactagtgcatgca Making 4tetO-IV-HR-template – 2F 
ST-839 TCGATACCACCTTTTActggatttcgtttacctcaccacc Making 4tetO-IV-HR-template – 2R 
ST-840 gtaaacgaaatccagTAAAAGGTGGTATCGAGGAATGGCA Making 4tetO-IV-HR-template – 3F 
















































Making meu27-S100Y-HR-template – F 





Making cup1-3xDSR construct – 1R 
ST-1046 gctaacgaaccttccttccattctc Making cup1-3xDSR construct – 2F 
ST-1047 cAAGGGAGccAaGGatAttGgaaagtggatgaacaagatcatttggagc Making cup1-3xDSR construct – 2R 
ST-1048 tcCaaTatCCtTggCTCCCTTgtaacttatgactctcgtttacac Making cup1-3xDSR construct – 3F 















Making cup1-3xDSR construct – 5F 


























































Making HR template for C-terminal tagging of cup1 with GFP 




























































To amplify 144-bp ura4 transcriptional terminator to replace 697 bp of 











To amplify 144-bp ura4 transcriptional terminator to replace 697 bp of 


















C-terminal tagging of arg11+ with mCherry using Bahler construct - R 
WC301-UR2-
C1-F           GGGAACCACATACAATGAATG 
C1 primer upstream of 5S rRNA.26 – F 
ChrIII control PCR and putative circle junction in UR-2 
WC305-UR2-
C2-F            TAGTCAGTATATACTGAGCGG 
C2 primer upstream of 5S rRNA.26 – F 
ChrIII control PCR and putative circle junction in UR-2 
WC306-UR2-
B1-R TCGCTGCTTATTGACTTTGAG 
B1 primer downstream of 5S rRNA.24 – R 
ChrIII control PCR and putative circle junction in UR-2 
WC308-UR2-
B2-R AACTGCTCTACTACTATAACG 
B2 primer downstream of 5S rRNA.24 – R 
ChrIII control PCR and putative circle junction in UR-2 
WC310-CHR3-
2-D1-R             ATCATCTCGATAAGTGCTTTC 
D1 primer downstream of 5S rRNA.26 – R 
ChrIII control PCR 
WC311-CHR3-
2-A-F             TCCGACTATTTGCATAAGACC 
A primer upstream of 5S rRNA.24 – F 
ChrIII control PCR 
WC312-CHR3-
2-D2-R            AGAACTTTGTTGTAGCCTGAG 
D2 primer downstream of 5S rRNA.26 – R 
ChrIII control PCR 
WC321-UR4-
UR17-G1-F           TTCTCCTTTGAACCCAGAAGG 
G1 primer upstream of LTR27 – F 
ChrIII control PCR and putative circle junction in UR-4 
WC325-UR4-
UR17-G2-F           AATTCCATCCAAATTCTCTGG 
G2 primer upstream of LTR27 – F 
ChrIII control PCR and putative circle junction in UR-4 
WC326-UR4-
F1-R TATCACAACAGTTCTGCAACG 
F1 primer downstream of LTR3 – R 
ChrIII control PCR and putative circle junction in UR-4 
WC328-UR4-
F2-R           TGGAAGCTTTGATAGAAAGGG 
F2 primer downstream of LTR3 – R 
ChrIII control PCR and putative circle junction in UR-4 
WC329-CHR3-
4-E-F ACGAATACGGTGTTGTATGAC 
E primer upstream of LTR3 – F 
ChrIII control PCR 
WC330-CHR3-
4-17-H-R           CGCATCGTTAATGAGTTCATC 
H primer downstream of LTR27 – R 
ChrIII control PCR 
WC313-PROBE-
925-F TAAGCCAAAGGGTCCAATTCC To amplify probe fragment at ~925 kb on chrIII – F 
WC314-PROBE-
925-R CATTCATTGTATGTGGTTCCC To amplify probe fragment at ~925 kb on chrIII – R 
WC315-PROBE-
520-F TATGCGGCAAAGTGCAATGTC To amplify probe fragment at ~520 kb on chrIII – F 
WC316-PROBE-
520-R TGTTGCTAAGAGTGATAGCAG To amplify probe fragment at ~520 kb on chrIII – R 
WC317-PROBE-
44-F ACTACAGCAGTATCCTTCATG To amplify probe fragment at ~44 kb on chrIII – F 
WC318-


































































Making 3xFLAG-Epe1-HR-template – R 
ST-36 CAGGAGTGTGTACAGGAGGT qPCR vps32+ - F 
ST-37 AGATGAATTGGCCAACGAGTT qPCR vps32+ - R 
ST-44 CTCGCCTGAAACTTGCTACA qPCR cgs1+ - F 
ST-45 GCACGAGGTTGATTACGCAT qPCR cgs1+ - R 
ST-48 GTCACGGGCGATTTTAGGAC qPCR ppr4+ - F 
ST-49 TCCCTTGTCCGGCAGAATAA qPCR ppr4+ - R 
ST-1012 TCTGCGTGACACTTGTTCGT qPCR grt1+ - F 
ST-1013 TAGAGACTCCAGCGCATCCT qPCR grt1+ - R 
ST-1010 GTCAGGTGCTCCTTGCAGAT qPCR eno102+ - F 
ST-1011 GCGTTCCTGCATAGATTGCG qPCR eno102+ - R 
ST-1006 ATTGGATAGGCGTCACCGTC qPCR aes1+ - F 
ST-1007 AGCCGGATCCTCATTGACAT qPCR aes1+ - R 
ST-1018 GATTGGGCCGAGTTGAAGGA qPCR cdc22+ - F 
ST-1019 AAGCAGTAGGCATTGGTGCT qPCR cdc22+ - R 
ST-1028 AAGCAGTAGGCATTGGTGCT qPCR fip1+ - F 
ST-1029 CCCTTTTTCACCGTTCTGCG qPCR fip1+ - R 
ST-1024 GCACCGGAGATGATACCCAG qPCR fio1+ - F 
ST-1025 GCACCATTTCCGATCGTTGG qPCR fio1+ - R 
ST-1022 TCACACATCGTGGCTATCCG qPCR cyp8+ - F 
ST-1023 TCGTTCACGAGATCCCTCCA qPCR cyp8+ - R 
ST-1040 CCTGCTGCCGAATTTCAACG qPCR pcn1+ - F 
ST-1041 TGCAGCTAAAACGAACACCC qPCR pcn1+ - R 
ST-1032 GTCTCCGGGTGCTACAGTTC qPCR mbx2+ - F 
ST-1033 GTGCGTTTGCCTACGATGAC qPCR mbx2+ - R 
ST-1038 CTCGTGTTCCTGAGACCACC qPCR nce103+ - F 
ST-1039 AACGAGGAACGACATTGGCA qPCR nce103+ - R 
ST-277 CATTTTGCGGGACAATGGGT qPCR cds1+ - F 
ST-278 CCTCCGTCCAAGTTGACGTT qPCR cds1+ - R 
ST-1068 tgctgaatgtaaccaacatca qPCR cen-IRC-L1 
ST-1069 gcctcaattgcctattagtgct qPCR cen-IRC-R1 
ST-1066 GGATAAGCCAATCATCGTTGAG qPCR tlh2 - F 
ST-1067 GTAGTTGACGCTCCTTGGAAG qPCR tlh2 - R 
ST-1070 CCGAGGCTTTCATAGCTTA qPCR S. cerevisiae CEN4 – F (for GFP spike-in qChIP) 
ST-1071 ACCGGAAGGAAGAATAAGAA qPCR S. cerevisiae CEN4 – R (for GFP spike-in qChIP) 
ST-161 CCCAATTGTTGTGATTGCTG qPCR S. octosporus CEN3 heterochromatin – F (for H3K9me2 spike-in qChIP) 


























Supplementary Table 4. Genomic coordinates used to generate heatmaps for 
heterochromatin islands.  
 
Chromosome Start End Name Reference 
I 578000 582000 Island 1 Zofall et al., Science, 2012 
I 2447000 2449000 Island 2 Zofall et al., Science, 2012 
I 2521000 2525000 Island 3 Zofall et al., Science, 2012 
I 3647000 3651000 Island 4 Zofall et al., Science, 2012 
I 3727000 3730000 Island 5 Zofall et al., Science, 2012 
I 4534000 4540000 Island 6 Zofall et al., Science, 2012 
I 4653000 4656000 Island 7 Zofall et al., Science, 2012 
II 898000 903000 Island 8 Zofall et al., Science, 2012 
II 1472000 1479000 Island 9 Zofall et al., Science, 2012 
II 1551000 1554000 Island 10 Zofall et al., Science, 2012 
II 1670000 1680000 Island 11 Zofall et al., Science, 2012 
II 1692000 1698000 Island 12 Zofall et al., Science, 2012 
II 1869000 1873000 Island 13 Zofall et al., Science, 2012 
II 2199000 2202000 Island 14 Zofall et al., Science, 2012 
II 2338000 2342000 Island 15 Zofall et al., Science, 2012 
II 3628000 3631000 Island 16 Zofall et al., Science, 2012 
II 3640000 3642000 Island 17 Zofall et al., Science, 2012 
III 958000 968000 Island 18 Zofall et al., Science, 2012 
III 1036000 1040000 Island 19 Zofall et al., Science, 2012 
III 2369000 2371000 Island 20 Zofall et al., Science, 2012 
III 2422000 2424000 Island 21 Zofall et al., Science, 2012 
I 1465847 1469848 HOOD-1 Yamanaka et al., Nature, 2013 
I 1564163 1568414 HOOD-2 Yamanaka et al., Nature, 2013 
I 2544835 2561773 HOOD-3 Yamanaka et al., Nature, 2013 
I 2927156 2941954 HOOD-4 Yamanaka et al., Nature, 2013 
I 2977013 2988899 HOOD-5 Yamanaka et al., Nature, 2013 
I 2994807 3009469 HOOD-6 Yamanaka et al., Nature, 2013 
I 3361499 3365727 HOOD-7 Yamanaka et al., Nature, 2013 
I 3736902 3743575 HOOD-8 Yamanaka et al., Nature, 2013 
I 3791825 3796114 HOOD-9 Yamanaka et al., Nature, 2013 
I 3996353 4000615 HOOD-10 Yamanaka et al., Nature, 2013 
I 4022326 4026545 HOOD-11 Yamanaka et al., Nature, 2013 
I 5069824 5083205 HOOD-12 Yamanaka et al., Nature, 2013 
I 5191103 5195325 HOOD-13 Yamanaka et al., Nature, 2013 
I 5195656 5199909 HOOD-14 Yamanaka et al., Nature, 2013 
I 5234000 5250176 HOOD-15 Yamanaka et al., Nature, 2013 
II 91600 101684 HOOD-16 Yamanaka et al., Nature, 2013 
II 347505 354250 HOOD-17 Yamanaka et al., Nature, 2013 
II 898107 902233 HOOD-18 Yamanaka et al., Nature, 2013 
II 1812684 1816937 HOOD-19 Yamanaka et al., Nature, 2013 
II 1965175 1969519 HOOD-20 Yamanaka et al., Nature, 2013 
II 2126590 2128479 HOOD-21 Yamanaka et al., Nature, 2013 
II 4414469 4418768 HOOD-22 Yamanaka et al., Nature, 2013 
II 4442538 4449562 HOOD-23 Yamanaka et al., Nature, 2013 
III 173841 176400 HOOD-24 Yamanaka et al., Nature, 2013 
III 254411 256353 HOOD-25 Yamanaka et al., Nature, 2013 
III 778123 782331 HOOD-26 Yamanaka et al., Nature, 2013 
III 1047657 1056145 HOOD-27 Yamanaka et al., Nature, 2013 
III 1168500 1176000 HOOD-28 Yamanaka et al., Nature, 2013 
III 1179500 1182650 HOOD-29 Yamanaka et al., Nature, 2013 
III 1196050 1196500 HOOD-30 Yamanaka et al., Nature, 2013 
III 1763512 1775613 HOOD-31 Yamanaka et al., Nature, 2013 
III 2320230 2324503 HOOD-32 Yamanaka et al., Nature, 2013 
I 239913 249656 SPAC806.04c & SPAC806.05 Wang et al., eLife, 2015 
I 4527389 4533031 LTR & SPAC27D7.11c Wang et al., eLife, 2015 
III 273261 279340 mae2 Wang et al., eLife, 2015 
II 2301681 2308661 pfk1/sad1 Sorida et al., PLoS Genet, 2019 
I 94000 97000 SPAC1F8.05 Gallagher et al., NSMB, 2019 
I 125000 129000 SPAC11D3.11c Gallagher et al., NSMB, 2019 
I 125000 129000 SPAC11D3.10 Gallagher et al., NSMB, 2019 
I 1036000 1042000 SPAC23C4.05c Gallagher et al., NSMB, 2019 
I 1036000 1042000 SPAC23C4.06c Gallagher et al., NSMB, 2019 
I 1513000 1517000 SPAC57A7.13 Gallagher et al., NSMB, 2019 
I 1513000 1517000 SPAC57A7.12 Gallagher et al., NSMB, 2019 
I 2147000 2150000 SPAC23C11.09 Gallagher et al., NSMB, 2019 
I 2174000 2179000 SPAC13F5.03c Gallagher et al., NSMB, 2019 
I 2395000 2398500 SPAC15F9.01c Gallagher et al., NSMB, 2019 
I 2977500 2985500 SPAPB1A11.02 Gallagher et al., NSMB, 2019 
I 3476500 3481000 SPAC328.03 Gallagher et al., NSMB, 2019 
I 5309000 5311500 SPNCRNA.1068 Gallagher et al., NSMB, 2019 
I 5309000 5311500 SPNCRNA.1069 Gallagher et al., NSMB, 2019 
I 5390000 5396000 SPAC3G6.07 Gallagher et al., NSMB, 2019 
II 102000 105000 SPBC359.01 Gallagher et al., NSMB, 2019 
II 167500 170500 SPBC1683.12 Gallagher et al., NSMB, 2019 
II 200500 203000 SPBC660.05 Gallagher et al., NSMB, 2019 
II 221500 224000 SPBC660.14 Gallagher et al., NSMB, 2019 
II 337500 340500 SPNCRNA.103 Gallagher et al., NSMB, 2019 
II 459500 464000 SPBC428.10 Gallagher et al., NSMB, 2019 
II 538000 541000 SPBC649.04 Gallagher et al., NSMB, 2019 
II 919500 922500 SPBC216.07c Gallagher et al., NSMB, 2019 
II 948000 951000 SPNCRNA.334 Gallagher et al., NSMB, 2019 
II 948000 951000 SPNCRNA.335 Gallagher et al., NSMB, 2019 
II 1223500 1226000 SPBC725.10 Gallagher et al., NSMB, 2019 
II 1309000 1312000 SPBC30B4.04c Gallagher et al., NSMB, 2019 
II 1495000 1499000 SPBC11B10.07c Gallagher et al., NSMB, 2019 
II 2184000 2186500 SPBC17G9.08c Gallagher et al., NSMB, 2019 
II 3344629 3348817 SPBC17D1.17 Gallagher et al., NSMB, 2019 
II 3530000 3532500 SPBC1105.12 Gallagher et al., NSMB, 2019 
II 3530000 3532500 SPBC1105.13c Gallagher et al., NSMB, 2019 
II 4103000 4108500 SPBC56F2.06 Gallagher et al., NSMB, 2019 
II 4409500 4414500 SPBC1289.14 Gallagher et al., NSMB, 2019 
III 31500 34500 SPCP20C8.03 Gallagher et al., NSMB, 2019 
III 34500 39000 SPCC1884.01 Gallagher et al., NSMB, 2019 
III 739000 742000 SPCC18B5.11c Gallagher et al., NSMB, 2019 
III 1265500 1268000 SPCC23B6.01c Gallagher et al., NSMB, 2019 
III 2072000 2075000 SPCPB1C11.02 Gallagher et al., NSMB, 2019 
III 2286000 2289500 SPCC965.04c Gallagher et al., NSMB, 2019 
III 2410325 2415970 SPCC569.08c Gallagher et al., NSMB, 2019 
III 2429000 2433000 SPCC569.03 Gallagher et al., NSMB, 2019 
 
